TABLE 2.

Immunogenicity of HPV-16 variant VLPs

HPV-16 variant VLP	L1 concn (ng/dose)	ELISA titer		Neutralization titer
		114K VLPs	GU-2 VLPs
114K	5,000	2,048,000	512,000	10−5
	500	256,000	128,000	10−4
	50	128,000	64,000	10−4
Rochester-1k	5,000	512,000	256,000	10−5
	500	256,000	128,000	10−4
	50	128,000	32,000	10−3
GU-1	5,000	1,024,000	64,000	10−5
	500	512,000	64,000	10−5
	50	128,000	32,000	10−4
GU-2	5,000	32,000	32,000	<10−2
	500	64,000	64,000	<10−2
	50	2,000	2,000	<10−2